For a patient receiving aripiprazole lauroxil 882 mg (3.2 mL) every 30 days and planning to increase to 1064 mg (3.9 mL) with a 6‑week dosing interval, should the first 1064 mg injection be given 30 days or 6 weeks after today’s dose?

Timing of First 1064 mg Aripiprazole Lauroxil Injection

Give the first 1064 mg injection 30 days from today's 882 mg injection, not 6 weeks. When transitioning to a higher dose with a longer dosing interval, you should maintain the current dosing schedule for the first injection of the new regimen, then shift to the new interval for subsequent doses 1.

Rationale for 30-Day Timing

The FDA labeling for aripiprazole lauroxil (ARISTADA) does not specify extending the interval when increasing the dose 1. The key principle is maintaining therapeutic aripiprazole concentrations during the transition. Since your patient is currently on a 30-day (monthly) schedule with 882 mg, giving the 1064 mg dose at 30 days ensures:

• Continuous therapeutic coverage without a gap in medication exposure
• Smooth transition to the higher dose before extending the interval
• Prevention of subtherapeutic levels that could occur with premature interval extension

Subsequent Dosing Schedule

After this first 1064 mg injection at 30 days:

• Wait 6 weeks (42 days) before the second 1064 mg injection
• Continue every 6 weeks thereafter

This approach is supported by pharmacokinetic modeling showing that the 1064 mg dose provides adequate aripiprazole concentrations throughout a 6-week interval 2, 3. The extended-release formulation has a duration of aripiprazole input into systemic circulation of approximately 46 days, with an elimination half-life of about 54 days 3.

Clinical Context

The 1064 mg dose was specifically developed to allow for extended dosing intervals while maintaining therapeutic concentrations within the established efficacious range 2, 3. Population pharmacokinetic modeling confirms that 1064 mg every 8 weeks (or 6 weeks in your case) maintains aripiprazole concentrations comparable to the proven efficacious monthly regimens 3, 4.

Common pitfall to avoid: Do not wait 6 weeks for the first 1064 mg injection, as this creates a 2-week gap beyond the patient's current 30-day schedule, potentially leading to subtherapeutic levels and symptom breakthrough.